GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Gland Pharma Ltd
Gland Pharma: Independent Director C.S.N. Murthy Resigns
MANAGEMENT ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 15 Jun 2026, 04:48 PM IST  ·  BSE ID: 1d189eeb-e41a-4383-a9c9-d1c87653974f
View Original BSE Filing (PDF)
💡
In Simple Terms
An independent director has left the company's board, while another director has been reappointed for another five years.
🤖 AI Summary
  • Independent Director Mr. C.S.N. Murthy resigned from Gland Pharma's board.
  • Resignation effective close of business hours on June 15, 2026.
  • Mr. Udo Johannes Vetter reappointed Independent Director for a second term.
  • Mr. Vetter's new term runs from July 21, 2026, to July 20, 2031.
🏢 How This Affects the Company
⚙️
Operational Impact
Director changes can affect board dynamics and governance oversight.
⚠️
Risk Impact
Director resignations can flag governance concerns or indicate shifts in board composition.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this director change.
👤
Who Is Affected
All shareholders are affected by changes in board composition and governance oversight.
🔍
Management Signal
The reappointment signals management's intent to maintain experienced leadership on the board.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next board meeting agenda and attendees.
Any further changes in director or management roles.
Upcoming AGM for formal director ratification, if applicable.
LOW RISK Standard director resignation and reappointment process with no immediate financial implications.
💡 Investor Takeaway
Gland Pharma's board sees a change with one director's resignation and another's reappointment for a five-year term effective July 21, 2026.
📅 Company Track Record
This filing follows recent reappointment intimation for Ms. Naina Lal Kidwai, indicating a focus on board governance continuity.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
Who resigned as an Independent Director from Gland Pharma?
Mr. C.S.N. Murthy resigned as an Independent Director of Gland Pharma, with his resignation effective June 15, 2026.
Who has been reappointed as an Independent Director at Gland Pharma?
Mr. Udo Johannes Vetter has been reappointed as an Independent Director for a second term from July 21, 2026, to July 20, 2031.
What is the effective date for Mr. Udo Johannes Vetter's reappointment?
Mr. Udo Johannes Vetter's reappointment is effective from July 21, 2026, for a five-year term.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.